Company Portage Biotech Inc OTC Bulletin Board
Equities
CA09852M1014
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ian Walters
CEO | Chief Executive Officer | 57 | 31/07/16 |
Allan Shaw
DFI | Director of Finance/CFO | 59 | 11/05/20 |
Steve Innaimo
COO | Chief Operating Officer | - | 07/01/19 |
Robert Kramer
CTO | Chief Tech/Sci/R&D Officer | 72 | 07/01/19 |
Justin Fairchild
PRN | Corporate Officer/Principal | - | 17/08/22 |
Brian Wiley
PRN | Corporate Officer/Principal | 56 | 14/02/22 |
Comptroller/Controller/Auditor | 68 | 31/12/19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Bailey
FOU | Founder | 68 | 31/12/72 |
Steven Mintz
BRD | Director/Board Member | 57 | 05/04/16 |
Robert Glassman
BRD | Director/Board Member | 62 | - |
Mark Simon
BRD | Director/Board Member | 62 | 14/02/22 |
Ian Walters
CEO | Chief Executive Officer | 57 | 31/07/16 |
Linda Kozick
BRD | Director/Board Member | 66 | 14/02/22 |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
644,229 | 4.70% | 3,156,722 $ |
Company contact information
![address Portage Biotech Inc](https://cdn.zonebourse.com/static/address/101597.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+27.29% | 47.07B | |
+46.73% | 42.06B | |
-3.48% | 39.98B | |
+36.89% | 33.02B | |
-7.79% | 27.9B | |
+18.98% | 27.63B | |
+49.17% | 14.37B | |
+44.14% | 13.45B | |
+1.43% | 12.03B |
- Stock Market
- Equities
- PRTG Stock
- Stock
- Company Portage Biotech Inc